Alamar Biosciences, Inc. (NAS: ALMR) Stock Analysis & Fundamentals | ScreenerHero

Create free account

ALMRAlamar Biosciences, Inc.

NAS · US · Healthcare · Medical Devices · alamarbio.com

24.95USD-4.52%Mkt Cap: 1.73B $P/E: —1d ago

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a prote…

Industry Peers

Medical Devices

Abbott Laboratories

$172.11BUSDP/E 27.7

Stryker Corporation

$126.97BUSDP/E 38.3

Boston Scientific Corporation

$66.32BUSDP/E 18.7

Edwards Lifesciences Corporation

$50.58BUSDP/E 47.5

Siemens Healthineers AG

$42.77BUSDP/E 18.9

$30.09BUSDP/E 33.5

GE HealthCare Technologies Inc.

$29.89BUSDP/E 15.8

Koninklijke Philips N.V.

$25.20BUSDP/E 23.9

Zimmer Biomet Holdings, Inc.

$18.14BUSDP/E 24.3

Sonova Holding AG

$14.05BUSDP/E 23.0

$12.57BUSDP/E 73.6

Insulet Corporation

$11.39BUSDP/E 38.4

Smith & Nephew plc

$10.66BUSDP/E 21.5

Globus Medical, Inc.

$10.98BUSDP/E 18.9

$8.74BUSDP/E 25.4

Glaukos Corporation

Bruker Corporation

Bio-Rad Laboratories, Inc.

$8.05BUSDP/E 50.2

Getinge AB (publ)

$5.50BUSDP/E 24.4

Sectra AB (publ)

$5.15BUSDP/E 95.3

iRhythm Holdings, Inc.

Haemonetics Corporation

$3.57BUSDP/E 38.3

Medacta Group SA

$3.18BUSDP/E 31.8

Integer Holdings Corporation

$3.38BUSDP/E 24.7

$2.71BUSDP/E 39.5

TransMedics Group, Inc.

$2.63BUSDP/E 17.4

Neogen Corporation

GN Store Nord A/S

$1.95BUSDP/E 51.0

UFP Technologies, Inc.

$1.99BUSDP/E 29.2

Elekta AB (publ)

Drägerwerk AG & Co. KGaA

$1.79BUSDP/E 10.8

Butterfly Network, Inc.

Embla Medical hf

$1.64BUSDP/E 19.9

Enovis Corporation

Drägerwerk AG & Co. KGaA

$1.53BUSDP/E 9.2

Integra LifeSciences Holdings Corporation

$1.45BUSDP/E 24.7

Inspire Medical Systems, Inc.

$1.49BUSDP/E 11.7

AdaptHealth Corp.

Alphatec Holdings, Inc.

Nolato AB (publ)

$1.28BUSDP/E 17.7

Medartis Holding AG

$1.29BUSDP/E 135.4

Vitrolife AB (publ)

CONMED Corporation

$1.36BUSDP/E 25.4

IRADIMED CORPORATION

$1.25BUSDP/E 53.4

$1.25BUSDP/E 102.9

QuidelOrtho Corporation

Avanos Medical, Inc.

$1.07BUSDP/E 41.6

Tandem Diabetes Care, Inc.

PROCEPT BioRobotics Corporation

Lumexa Imaging Holdings, Inc.

Kuros Biosciences AG

$935.36MUSDP/E 346.3

Eckert & Ziegler SE

$961.77MUSDP/E 17.9

$842.11MUSDP/E 30.3

Synektik Spólka Akcyjna

$777.63MUSDP/E 20.0

MedCap AB (publ)

$744.00MUSDP/E 34.6

Xvivo Perfusion AB (publ)

$741.20MUSDP/E 87.2

Beta Bionics, Inc.

Tactile Systems Technology, Inc.

$663.38MUSDP/E 33.8

Cerus Corporation

Cytek Biosciences, Inc.

Ion Beam Applications SA

$536.61MUSDP/E 40.5

NeuroPace, Inc.

OrthoPediatrics Corp.

Orthofix Medical Inc.

Viemed Healthcare, Inc.

$463.49MUSDP/E 32.7

Pacific Biosciences of California, Inc.

Varex Imaging Corporation

ClearPoint Neuro, Inc.

Delcath Systems, Inc.

$443.60MUSDP/E 1285.0

$393.08MUSDP/E 26.9

Revenio Group Oyj

$402.22MUSDP/E 21.6

Mobia Medical, Inc.

Electromed, Inc.

$354.39MUSDP/E 36.6

CellaVision AB (publ)

$311.65MUSDP/E 24.3

Perspective Therapeutics, Inc.

Standard BioTools Inc.

CapsoVision, Inc.

908 Devices Inc.

Treace Medical Concepts, Inc.

$269.90MUSDP/E 29.5

Sight Sciences, Inc.

Senseonics Holdings, Inc.

TriSalus Life Sciences, Inc.

Eurobio Scientific Société anonyme

$230.91MUSDP/E 44.9

Median Technologies SA

Lucid Diagnostics Inc.

Quanterix Corporation

InfuSystem Holdings, Inc.

$186.48MUSDP/E 25.0

Apyx Medical Corporation

Quantum-Si incorporated

AVITA Medical, Inc.

EKF Diagnostics Holdings plc

$118.33MUSDP/E Infinity

Neuronetics, Inc.

C-Rad AB (publ)

$112.94MUSDP/E 40.7

Paxman AB (publ)

BICO Group AB (publ)

Rapid Micro Biosystems, Inc.

Hyperfine, Inc.

Sedana Medical AB (publ)

Sera Prognostics, Inc.

$78.56MUSDP/E 124.9

Outset Medical, Inc.

Creo Medical Group PLC

Medicalgorithmics S.A.

Senzime AB (publ)

Xtant Medical Holdings, Inc.

$62.14MUSDP/E 44.3

Pulmonx Corporation

Gentian Diagnostics ASA

Bactiguard Holding AB (publ)

Envoy Medical, Inc.

Sequana Medical NV

Spectral AI, Inc.

Theralase Technologies Inc.

Sensus Healthcare, Inc.

$46.44MUSDP/E 15.6

QT Imaging Holdings, Inc.

electroCore, Inc.

OssDsign AB (publ)

Episurf Medical AB (publ)

Mentice AB (publ)

Nortech Systems Incorporated

$39.88MUSDP/E 37.6

SciBase Holding AB (publ)

Q-linea AB (publ)

Perimeter Medical Imaging AI, Inc.

Accuray Incorporated

Acarix AB (publ)

BrainCool AB (publ)

aap Implantate AG

Cytosorbents Corporation

Integrum AB (publ)

NeuroOne Medical Technologies Corporation

Inspiration Healthcare Group plc

RUA Life Sciences plc

$16.53MUSDP/E Infinity

Geratherm Medical AG

IRIDEX Corporation

Picard Medical, Inc.

Boule Diagnostics AB (publ)

Observe Medical ASA

Ventripoint Diagnostics Ltd.

VolitionRx Limited

Aurora Spine Corporation

$11.72MUSDP/E 34.2

MedX Health Corp

Adagio Medical Holdings, Inc.

Iconovo AB (publ)

Clinical Laserthermia Systems AB (publ)

Nexalin Technology, Inc.

Sintx Technologies, Inc.

Co-Diagnostics, Inc.

HeartSciences Inc.

enVVeno Medical Corporation

Bluelinea Société Anonyme

Qlife Holding AB (publ)

20/20 Biolabs, Inc.

Vivos Therapeutics, Inc.

Surgical Innovations Group plc

Intelligent Bio Solutions Inc.

Biomerica, Inc.

ScandiDos AB (publ)

Beyond Air, Inc.

Tenon Medical, Inc.

SpectraCure AB (publ)

Autonomix Medical, Inc.

ENvue Medical, Inc.

Therma Bright Inc.

Catheter Precision, Inc.

INVO Fertility, Inc.

$2.02MUSDP/E 0.0

Aethlon Medical, Inc.

Adiuvo Investments S.A.

Luxbright AB (publ)

Bluejay Diagnostics, Inc.

STRATA Skin Sciences, Inc.

Imaging Dynamics Company Ltd.

DIH Holding US, Inc.

Telesis Bio, Inc.

Nemaura Medical Inc.

Acutus Medical, Inc.

Viveve Medical, Inc.

ThermoGenesis Holdings, Inc.

Minerva Surgical, Inc.

Motus GI Holdings, Inc.

Bruker Corporation

Indicators:|

Headline	Source	Time
This week
Braveheart, Attovia join next wave of biotech IPOs The two startups are the third and fourth, respectively, to outline offerings this month and aim to capitalize on momentum that’s already yielded several big-ticket IPOs.	BioPharma Dive	2d
Alamar Hits A High Note On Alzheimer's Buzz If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.	Trefis	Jul 13
Older
Cathie Wood Doubles Down on AI, Loads Up on Tesla, Palantir, and SpaceX	GuruFocus.com	Jul 1
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought	Motley Fool	Jun 23
Evaluating Alamar Biosciences (ALMR) Valuation As Shares Show Modest Year To Date Gains	Simply Wall St.	May 14
Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls	The Fly	May 12